Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorUniversidade Federal do Rio de Janeiro (UFRJ)-
Autor(es): dc.contributorBrazilian Society for Infectious Diseases-
Autor(es): dc.contributorSociedade Mineira de Infectologia - SMI-
Autor(es): dc.contributorUniversidad Autónoma de Santo Domingo (UASD)-
Autor(es): dc.contributorUniversidade Federal do Paraná (UFPR)-
Autor(es): dc.contributorComisión Nacional de Arbitraje Médico-
Autor(es): dc.contributorFiocruz-
Autor(es): dc.contributorUniversidad Central del Ecuador-
Autor(es): dc.contributorUniversidade de São Paulo (USP)-
Autor(es): dc.contributorAC Camargo Cancer Center-
Autor(es): dc.contributorOswaldo Cruz Foundation-
Autor(es): dc.contributorHTAnalyze Consulting and Training-
Autor(es): dc.contributorHospital Salvador Bienvenido Gautier-
Autor(es): dc.contributorInstitute of Infectious Diseases Emilio Ribas-
Autor(es): dc.contributorFundación Universitaria Autónoma de Las Américas-Institución Universitaria Visión de Las Américas-
Autor(es): dc.contributorUniversidad Científica del Sur-
Autor(es): dc.contributorLebanese American University-
Autor(es): dc.contributorLatin American Network of Coronavirus Disease 2019 – COVID-19 Research (LANCOVID-19)-
Autor(es): dc.contributorPosgrado de Medicina Interna-
Autor(es): dc.creatorBarbosa, Alexandre Naime-
Autor(es): dc.creatorChebabo, Alberto-
Autor(es): dc.creatorStarling, Carlos-
Autor(es): dc.creatorPérez, Clevy-
Autor(es): dc.creatorCunha, Clóvis Arns-
Autor(es): dc.creatorde Luna, David-
Autor(es): dc.creatorNunes, Estevão Portela-
Autor(es): dc.creatorZambrano, Gabriela-
Autor(es): dc.creatorFerreira, Juliana Carvalho-
Autor(es): dc.creatorCroda, Julio-
Autor(es): dc.creatorFalavigna, Maicon-
Autor(es): dc.creatorGomes-da-Silva, Monica Maria-
Autor(es): dc.creatorThormann, Monica-
Autor(es): dc.creatorCimerman, Sergio-
Autor(es): dc.creatorParahiba, Suena Medeiros-
Autor(es): dc.creatorTanni, Suzana-
Autor(es): dc.creatorBernardo, Wanderley Marques-
Autor(es): dc.creatorRodriguez-Morales, Alfonso J.-
Data de aceite: dc.date.accessioned2025-08-21T22:13:29Z-
Data de disponibilização: dc.date.available2025-08-21T22:13:29Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2023-11-30-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1186/s12941-023-00623-w-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/308982-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/308982-
Descrição: dc.descriptionBackground: Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. Considering the particular impact of COVID-19 in the Americas, this document aims to present recommendations for the pharmacological treatment of COVID-19 specific to this population. Methods: Fifteen experts, members of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API) make up the panel responsible for developing this guideline. Questions were formulated regarding prophylaxis and treatment of COVID-19 in outpatient and inpatient settings. The outcomes considered in decision-making were mortality, hospitalisation, need for mechanical ventilation, symptomatic COVID-19 episodes, and adverse events. In addition, a systematic review of randomised controlled trials was conducted. The quality of evidence assessment and guideline development process followed the GRADE system. Results: Nine technologies were evaluated, and ten recommendations were made, including the use of tixagevimab + cilgavimab in the prophylaxis of COVID-19, tixagevimab + cilgavimab, molnupiravir, nirmatrelvir + ritonavir, and remdesivir in the treatment of outpatients, and remdesivir, baricitinib, and tocilizumab in the treatment of hospitalised patients with severe COVID-19. The use of hydroxychloroquine or chloroquine and ivermectin was discouraged. Conclusion: This guideline provides recommendations for treating patients in the Americas following the principles of evidence-based medicine. The recommendations present a set of drugs that have proven effective in the prophylaxis and treatment of COVID-19, emphasising the strong recommendation for the use of nirmatrelvir/ritonavir in outpatients as the lack of benefit from the use of hydroxychloroquine and ivermectin.-
Descrição: dc.descriptionInfectious Diseases Department - Botucatu School of Medicine - UNESP, Av. Prof. Mário R. G. Montenegro, s/n, SP-
Descrição: dc.descriptionUniversidade Federal do Rio de Janeiro, Avenida Professor Rodolpho Paulo Rocco, 255, 50. Andar, RJ-
Descrição: dc.descriptionBrazilian Society for Infectious Diseases, Rua Teixeira da Silva, 660, SP-
Descrição: dc.descriptionSociedade Mineira de Infectologia - SMI, Avenida João Pinheiro, 161, MG-
Descrição: dc.descriptionUniversidad Autónoma de Santo Domingo (UASD), Avenida Simón Bolívar, 902-
Descrição: dc.descriptionUniversidade Federal do Paraná, Rua XV de Novembro, 1299, PR-
Descrição: dc.descriptionComisión Nacional de Arbitraje Médico, C Mitla, 250-
Descrição: dc.descriptionInstituto Nacional de Infectologia (INI) Fiocruz, Avenida Brasil, 4365, RJ-
Descrição: dc.descriptionFaculty of Medicine Department of Infectious Diseases Universidad Central del Ecuador-
Descrição: dc.descriptionDivisão de Pneumologia Instituto do Coração Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Universidade de São Paulo, Avenida Dr. Enéas Carvalho de Aguiar, 44, SP-
Descrição: dc.descriptionIntensive Care Unit AC Camargo Cancer Center, Rua Prof. Antônio Prudente, 211, SP-
Descrição: dc.descriptionOswaldo Cruz Foundation, Avenida Costa e Silva, s/n, Cidade Universitária, MS-
Descrição: dc.descriptionHTAnalyze Consulting and Training, Rua João Abbott, 109, RS-
Descrição: dc.descriptionInfectious Disease Control Service Clinical Hospital Universidade Federal Do Paraná, Rua General Carneiro, 181, PR-
Descrição: dc.descriptionHospital Salvador Bienvenido Gautier, Calle Alexander Fleming, 177-
Descrição: dc.descriptionInstitute of Infectious Diseases Emilio Ribas, Avenida Dr. Arnaldo, 165, SP-
Descrição: dc.descriptionUniversidade Estadual Paulista Julio de Mesquita Filho, Distrito de Rubiao Jr, s/n, SP-
Descrição: dc.descriptionMedical Education Development Center (CEDEM) of Medical Faculty of São Paulo University (FMUSP), SP-
Descrição: dc.descriptionGrupo de Investigación Biomedicina Faculty of Medicine Fundación Universitaria Autónoma de Las Américas-Institución Universitaria Visión de Las Américas, Risaralda-
Descrição: dc.descriptionClinical Epidemiology and Biostatistics Faculty of Health Sciences Universidad Científica del Sur-
Descrição: dc.descriptionGilbert and Rose-Marie Chagoury School of Medicine Lebanese American University, P.O. Box 36-
Descrição: dc.descriptionLatin American Network of Coronavirus Disease 2019 – COVID-19 Research (LANCOVID-19), Risaralda-
Descrição: dc.descriptionPontificia Universidad Católica del Ecuador Facultad de Medicina Posgrado de Medicina Interna-
Descrição: dc.descriptionInfectious Diseases Department - Botucatu School of Medicine - UNESP, Av. Prof. Mário R. G. Montenegro, s/n, SP-
Descrição: dc.descriptionUniversidade Estadual Paulista Julio de Mesquita Filho, Distrito de Rubiao Jr, s/n, SP-
Idioma: dc.languageen-
Relação: dc.relationAnnals of Clinical Microbiology and Antimicrobials-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectGuidelines-
Palavras-chave: dc.subjectSARS-CoV-2-
Palavras-chave: dc.subjectTherapy-
Palavras-chave: dc.subjectTreatment-
Título: dc.titlePan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API)-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.